Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hatchtech Pty. Ltd.

www.hatchtech.com.au

Latest From Hatchtech Pty. Ltd.

Keeping Track: US FDA Approves Siliq, Accepts Mylan/Biocon Pegfilgrastim Biosimilar

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Regulation

FDA Combs Out Knotty Development Issues For Head Lice Products

Draft guidance notes special safety considerations for the treatments, which would usually be used on healthy kids.

BioPharmaceutical United States

Deals Shaping The Medical Industry, October 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical Tools – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2015.

BioPharmaceutical Medical Device

Keeping Track: Allergan Antipsychotic Vraylar Approved; First-Line Imbruvica Claim Submitted

The latest drug development news and highlights from our FDA Performance Tracker.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Hatchtech Pty. Ltd.
  • Senior Management
  • Hugh Alsop, CEO
    Vern Bowles, PhD, CSO
  • Contact Info
  • Hatchtech Pty. Ltd.
    Phone: 439 080 353
    697 Burke Rd., Ste. 201
    Camberwell, 3124
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register